West Branch Capital LLC Bristol Myers Squibb CO Transaction History

West Branch Capital LLC

$285 Million
Q1 2025

A detailed history of West Branch Capital LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, West Branch Capital LLC holds 2,863 shares of BMY stock, worth $135,190. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,863

Previous 2,863 -0.0%

Holding current value

$135,190

Previous $161,000 8.07%

% of portfolio

0.06%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$39.66 - $51.75 $515 - $672	13 Added 0.46%	2,863 $148,000
Q2 2024 Jul 26, 2024	BUY	$40.25 - $52.99 $24,150 - $31,794	600 Added 26.67%	2,850 $118,000
Q1 2024 Apr 23, 2024	SELL	$47.98 - $54.4 $6,957 - $7,888	-145 Reduced 6.05%	2,250 $122,000
Q4 2023 Jan 19, 2024	SELL	$48.48 - $57.85 $73,641 - $87,874	-1,519 Reduced 38.81%	2,395 $122,000
Q3 2023 Oct 20, 2023	SELL	$57.89 - $64.73 $4,746 - $5,307	-82 Reduced 2.05%	3,914 $227,000
Q2 2023 Aug 04, 2023	SELL	$63.71 - $70.74 $22,617 - $25,112	-355 Reduced 8.16%	3,996 $255,000
Q1 2023 Apr 20, 2023	SELL	$65.71 - $74.53 $12,616 - $14,309	-192 Reduced 4.23%	4,351 $301,000
Q4 2022 Jan 27, 2023	BUY	$68.48 - $81.09 $547 - $648	8 Added 0.18%	4,543 $0
Q3 2022 Oct 19, 2022	BUY	$0.13 - $76.84 $1 - $614	8 Added 0.18%	4,535 $322,000
Q2 2022 Jul 28, 2022	BUY	$72.62 - $79.98 $22,947 - $25,273	316 Added 7.5%	4,527 $349,000
Q1 2022 May 03, 2022	SELL	$61.48 - $73.72 $17,952 - $21,526	-292 Reduced 6.48%	4,211 $308,000
Q4 2021 Jan 24, 2022	SELL	$53.63 - $62.52 $3,646 - $4,251	-68 Reduced 1.49%	4,503 $281,000
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $3,195 - $3,742	-54 Reduced 1.17%	4,571 $270,000
Q2 2021 Aug 17, 2021	BUY	$61.91 - $67.42 $742 - $809	12 Added 0.26%	4,625 $309,000
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $78,684 - $88,497	-1,326 Reduced 22.33%	4,613 $291,000
Q4 2020 Feb 08, 2021	SELL	$57.74 - $65.43 $29,909 - $33,892	-518 Reduced 8.02%	5,939 $368,000
Q3 2020 Oct 13, 2020	SELL	$57.43 - $63.64 $565,168 - $626,281	-9,841 Reduced 60.38%	6,457 $389,000
Q2 2020 Jul 08, 2020	BUY	$54.82 - $64.09 $355,836 - $416,008	6,491 Added 66.19%	16,298 $958,000
Q1 2020 Apr 20, 2020	BUY	$46.4 - $67.43 $15,822 - $22,993	341 Added 3.6%	9,807 $547,000
Q4 2019 Jan 07, 2020	BUY	$49.21 - $64.19 $205,107 - $267,543	4,168 Added 78.67%	9,466 $608,000
Q3 2019 Oct 23, 2019	SELL	$42.77 - $50.71 $19,888 - $23,580	-465 Reduced 8.07%	5,298 $269,000
Q2 2019 Aug 05, 2019	SELL	$44.62 - $49.34 $14,635 - $16,183	-328 Reduced 5.38%	5,763 $261,000
Q1 2019 Apr 30, 2019	SELL	$45.12 - $53.8 $4,692 - $5,595	-104 Reduced 1.68%	6,091 $291,000
Q4 2018 Feb 07, 2019	SELL	$48.76 - $63.23 $57,195 - $74,168	-1,173 Reduced 15.92%	6,195 $322,000
Q3 2018 Oct 16, 2018	SELL	$55.19 - $62.25 $275 - $311	-5 Reduced 0.07%	7,368 $457,000
Q2 2018 Aug 02, 2018	BUY	$50.53 - $62.98 $147,598 - $183,964	2,921 Added 65.61%	7,373 $408,000
Q1 2018 May 02, 2018	BUY	$59.92 - $68.98 $266,763 - $307,098	4,452 New	4,452 $282,000

Others Institutions Holding BMY

# of Institutions

2,801

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $100B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West Branch Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Branch Capital LLC with notifications on news.

Account

West Branch Capital LLC Bristol Myers Squibb CO Transaction History